Last week (March 5, 2019) the US Food and Drug Administration (FDA) approved a new drug treatment for depression. It’s the first antidepressant drug in roughly 30 years to have an entirely new mechanism of action providing high hopes among chronic depression sufferers that this new drug will bring relief where the others have failed.… Read More
In Dr. Yapko’s Blog #4, some after thoughts about an interview with Dr. Oz. Dr. Oz did a special focus on depression in his radio interview with me, psychologist, Dr. Michael Yapko, and psychiatrist, Dr. Peter Freed. The interview included looking at genetic contributions, neurological signatures, medical and biological aspects of depression as well as… Read More
In Dr. Yapko’s Blog #2, he provides a simple introduction to the issue of antidepressant medications. He tells us that the use of these medications are second only to cholesterol lowering drugs in the U.S. and are most commonly prescribed by general practitioners, not psychiatrists. Controversy surrounds the use and benefits of these medications and… Read More
